Skip to main content

Table 4 Adjusted odds/risk ratios and risk differences between CNI users and non-CNI users after adjustments for the logistic regression analysis, propensity scoring, and IPW

From: Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry—a historical cohort study

Effect

Estimate

(95% CI)

Odds ratio with outcome model

1.12

(0.42–3.00)

Risk difference with standardization

0.01

(− 0.04 to 0.06)

Risk difference with IPW

0.05

(− 0.04 to 0.24)

Risk ratio with standardization

1.18

(0.47–2.16)

Risk ratio with IPW

1.8

(0.41–4.66)

  1. CNI calcineurin inhibitor, IPW inverse probability weighting, CI confidence interval